Avodart Cost in Tennessee 2026: What You'll Actually Pay for Dutasteride

Start With the FDA Label

Dutasteride is a 5-alpha-reductase inhibitor. The current DailyMed label for Avodart states that it is indicated for treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of BPH-related surgery. [1] Randomized trial data in men with enlarged prostates support improvements in symptoms, urinary flow, prostate volume, and progression outcomes in the studied populations. [8,9] The label also describes use with tamsulosin for symptomatic BPH; four-year CombAT data evaluated dutasteride, tamsulosin, and their combination in the trial's defined population. [12]

That label matters for cost because insurers usually adjudicate claims against medically accepted indications, formulary rules, and plan design. Dutasteride is commonly discussed online for androgenetic alopecia, but hair-loss use is off-label in the United States. A dermatologist may consider off-label use in selected patients, yet that clinical possibility does not create an insurance entitlement.

TennCare in 2026

The July 15, 2026 TennCare preferred drug list identifies dutasteride capsules as a preferred drug in the androgen hormone inhibitor category and marks them with a quantity-limit notation. The same section states that androgen hormone inhibitors are covered for males only. [2]

That is the most defensible current Tennessee Medicaid statement from the available primary source. It is not the same as saying every dutasteride prescription is covered, that hair-loss use is covered, or that a specific copay applies. TennCare claims can still be affected by eligibility, managed-care organization procedures, quantity limits, diagnosis, prescriber documentation, and pharmacy network rules. Patients should ask the pharmacy to process the claim and ask the prescriber whether the documented indication matches coverage criteria.

Commercial Insurance in Tennessee

Commercial plans in Tennessee vary widely. Cigna's official 2026 Plus Tennessee 5-tier drug list, for example, lists dutasteride 0.5 mg capsules on tier 2, but that single individual-and-family plan document does not represent every employer, exchange, Medicare, or self-funded plan. [3] Different plans and discount-card cash transactions can produce different prices for the same capsule.

The cleanest way to estimate cost is to check the exact product at the pharmacy: generic dutasteride 0.5 mg capsule, quantity, days' supply, pharmacy NPI, and plan. If the prescription is for BPH, the claim may behave differently than an off-label hair-loss claim. If the plan denies the claim, the denial reason matters: noncovered diagnosis, prior authorization needed, quantity limit, nonpreferred brand, or pharmacy network restriction each has a different fix.

Date-Stamped Cash-Price Benchmarks

Prices checked on August 4, 2026 show why brand and generic must be quoted separately. Drugs.com's national cash-price page listed thirty 0.5 mg generic capsules at $8.12 to $16.92. [13] Its separate Avodart page listed thirty 0.5 mg brand capsules at $1,613.28. [14] These are cash-paying benchmarks, not Tennessee guarantees, insured copays, or promises that a given pharmacy has stock.

A Tennessee pharmacy can quote a different amount because location, supplier, discount program, and inventory affect the transaction. Compare the same strength, quantity, manufacturer, and NDC, then ask whether the quoted amount uses insurance or a discount program. FDA's National Drug Code Directory explains what an NDC identifies and also cautions that inclusion in the directory is not itself proof of FDA approval. [15]

Brand Avodart vs Generic Dutasteride

For most patients, generic dutasteride is the first cost comparison because it contains the same active ingredient and is widely dispensed. FDA requires an approved generic to have the same active ingredient and provide the same clinical benefit and risks as its brand-name counterpart. [6] The FDA Orange Book separately identifies approved products and therapeutic-equivalence evaluations; its current prescription-drug list includes 0.5 mg oral dutasteride capsules. [11] Brand Avodart may cost more or require a formulary exception if a plan prefers generic dutasteride. A brand request should have a specific reason, such as documented intolerance or availability issues, rather than a vague assumption that brand is stronger.

Discount-card prices change frequently and are not insurance. A coupon may be cheaper than a plan copay for one person and more expensive for another. Using a coupon may also mean the purchase does not count toward a deductible or out-of-pocket maximum. That tradeoff is worth checking before paying cash.

Dutasteride for Hair Loss

Evidence exists for dutasteride in androgenetic alopecia, including randomized trials and systematic reviews, but this is still a different claim from "FDA-approved for hair loss" or "covered by Tennessee insurance." A dose-ranging randomized trial compared dutasteride with finasteride and placebo in men with androgenetic alopecia. [7] A 2019 systematic review concluded that dutasteride appeared more effective than finasteride for androgenetic alopecia, with similar rates of adverse reactions in included studies. [4] Those findings support clinical discussion; they do not support a Tennessee price guarantee.

Patients who could become pregnant or who may handle opened capsules need special counseling because dutasteride can cause fetal harm. The Avodart label warns that women who are pregnant should not handle the capsules if they are leaking because dutasteride may be absorbed through the skin. [1]

Compounded Dutasteride in Tennessee

Tennessee pharmacy rules require compounded drug products to comply with standards established by the United States Pharmacopeia and other applicable requirements. [5] That does not mean every compounded dutasteride formulation is lawful, available, covered, sterile, stable, or clinically appropriate.

Compounded products are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or manufacturing quality. FDA warns that poor compounding practices can produce contamination or incorrect strength and says compounded drugs should be reserved for a medical need that an approved product cannot meet. [10] A patient considering a compounded topical or custom dose should ask whether an FDA-approved product can meet the clinical need, whether the compounding pharmacy is properly licensed, what beyond-use dating and quality standards apply, and whether the product will be covered or entirely cash-pay.

Bottom Line

The practical 2026 Tennessee answer is that dutasteride is FDA-approved for symptomatic BPH in men with an enlarged prostate; TennCare's July 2026 PDL lists dutasteride capsules as preferred for covered males with quantity limits; commercial coverage varies by plan; hair-loss use is off-label; and compounded products require pharmacy-specific verification. Any exact cash price should be checked at the dispensing pharmacy on the day of fill. Readers comparing long-term treatment costs can also review dutasteride costs versus alternatives.